Señales en vivo de SAVA | Maximiza tus Ganancias con Getagraph.com

COMPRAR 112100 min ago

@ $24.09

Emitido: 14 feb 2024 @ 15:43

Retorno: -8.47%

Señal anterior: feb 13 - 15:46

Señal anterior: Vender

Retorno: 0.75 %

Live Chart Being Loaded With Signals

Commentary (2 may 2024 @ 13:04):

Stats
Volumen de hoy	470 851
Volumen promedio	767 552
Capitalización de mercado	953.12M
EPS	$0 ( 2024-04-29 )
Próxima fecha de ganancias	( $-0.510 ) 2024-05-06
Last Dividend	$5.25 ( 2012-12-13 )
Next Dividend	$0 ( N/A )
P/E	-9.50
ATR14	$0.0260 (0.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-26	Robertson Sanford	Buy	69 000	Common Stock
2024-01-03	Robertson Sanford	Buy	354 740	Common Stock Warrant
2024-04-26	Robertson Sanford	Sell	46 000	Common Stock Warrant
2024-01-03	Robertson Sanford	Buy	72 000	Common Stock Warrant
2024-04-23	Barry Richard	Buy	176 085	Common Stock

INSIDER POWER
71.89
Last 91 transactions
Buy: 2 502 072 \| Sell: 652 285

Volumen Correlación

Largo: -0.11 (neutral)

Corto: -0.52 (weak negative)

Signal:(55.623) Neutral

Cassava Sciences Inc Correlación

10 Correlaciones Más Positivas
CBIO	0.848
GOOD	0.844
ALXO	0.828
ANGN	0.828
CTBI	0.825
MIRO	0.819
RPRX	0.813
CMPX	0.813
DCRC	0.808
BLUE	0.806

10 Correlaciones Más Negativas
RNA	-0.87
VKTX	-0.844
BWMX	-0.833
MTRY	-0.832
DKDCA	-0.826
CFFE	-0.823
ROCL	-0.821
LRMR	-0.821
AMPH	-0.814
EDTX	-0.811

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cassava Sciences Inc Correlación - Moneda/Commodity

0.32
( neutral )

-0.09
( neutral )

0.00
( neutral )

-0.02
( neutral )

0.54
( weak )

-0.20
( neutral )

Cassava Sciences Inc Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-1.53M (0.00 %)
EPS:	$-2.32

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-1.53M (0.00 %)
EPS:	$-2.32

FY	2022
Ingresos:	$-1 800.00
Beneficio Bruto:	$-1.30M (72 377.78 %)
EPS:	$-1.800

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.820

Financial Reports:

No articles found.

Cassava Sciences Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Cassava Sciences Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$14.00	2010-12-13
Last Dividend	$5.25	2012-12-13
Next Dividend	$0	N/A
Payout Date	2012-12-24
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	$19.25	--
Avg. Dividend % Per Year	0.00%	--
Score	0.22	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-10-04)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.22

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2010	$14.00	37.20%
2011	$0	0.00%
2012	$5.25	19.20%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-40.28	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.624	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.560	1.500	-7.33	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	9.13	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	8.60	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	8.53	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-1.944	2.00	-0.648	-1.296	[0 - 30]
freeCashFlowPerShareTTM	-1.954	2.00	-0.977	-1.954	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.348	1.000	7.53	7.53	[0.2 - 0.8]
operatingProfitMarginTTM	-45.29	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.0155	0.800	-3.23	-2.58	[0.5 - 2]
Total Score				-1.853

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-9.88	1.000	-1.099	0	[1 - 100]
returnOnEquityTTM	-0.560	2.50	-4.71	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.954	2.00	-0.651	-1.954	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.944	2.00	-0.648	-1.296	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0432	1.500	-3.62	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-34.93	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-2.91

Cassava Sciences Inc

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

Actualizaciones en tiempo real para Cassava Sciences Inc [SAVA]

Upcoming Earnings Alert

Cassava Sciences Inc Dividend Information - No Dividend Player

Dividend Commentary

Top 10 dividend Companies for NASDAQ

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)